news_image.jpg

Potential new treatment for diabetes and fatty liver disease

12 Apr 2019



A study, published in the British Journal of Pharmacology, indicates a new molecule, which promotes the production of the FGF21 hormone, has anti-diabetic and anti-obesogenic effects that may be useful in developing treatments for non-alcoholic fatty liver disease and diabetes.

Science Daily



Issue 43 - Spring 2019

Latest Newsletter

Issue 43 - Spring 2019

Issue 43 - Spring 2019

Newsletter Archive

Previous newsletters can be viewed and downloaded from the archive.

Newsletter Archive